| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 17.147 | 39.671 | 52.252 | 55.925 | 64.562 | 47.540 | 48.727 | 61.016 |
| Total Income - EUR | - | - | 18.973 | 39.671 | 52.252 | 59.116 | 64.580 | 47.540 | 48.727 | 61.016 |
| Total Expenses - EUR | - | - | 18.222 | 38.596 | 51.582 | 58.273 | 59.564 | 43.155 | 42.912 | 62.416 |
| Gross Profit/Loss - EUR | - | - | 752 | 1.075 | 671 | 842 | 5.016 | 4.385 | 5.814 | -1.400 |
| Net Profit/Loss - EUR | - | - | 574 | 677 | 148 | 251 | 4.486 | 3.979 | 5.364 | -2.338 |
| Employees | - | - | 2 | 0 | 2 | 3 | 2 | 1 | 1 | 2 |
Check the financial reports for the company - Fda Supermerkatti Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | 17.601 | 18.678 | 29.353 | 17.539 | 13.670 | 17.274 | 28.810 | 16.264 |
| Inventories | - | - | 17.053 | 17.801 | 28.305 | 17.108 | 12.902 | 12.914 | 23.291 | 12.950 |
| Receivables | - | - | 492 | 611 | 623 | 0 | 469 | 1.651 | 1.597 | 87 |
| Cash | - | - | 56 | 265 | 425 | 431 | 299 | 2.709 | 3.922 | 3.227 |
| Shareholders Funds | - | - | 617 | 1.283 | 1.405 | 1.630 | 6.079 | 10.077 | 11.444 | 9.042 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 16.984 | 17.395 | 27.947 | 15.908 | 7.591 | 7.197 | 17.366 | 7.221 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Fda Supermerkatti Srl